Thanatop: a novel 5-nitrofuran that is a highly active, cell-permeable inhibitor of topoisomerase II.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Cancer Research

• Publication date

  2007-05-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1158/0008-5472.CAN-07-0393PMID 17483360
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A Topoisomerase IIß-Mediated dsDNA Break Required for Regulated Transcription

  2006cited by this paper
• Role of apoptotic nuclease caspase-activated DNase in etoposide-induced treatment-related acute myelogenous leukemia.

  2006cited by this paper
• Multiple mechanisms induce transcriptional silencing of a subset of genes, including oestrogen receptor α, in response to deacetylase inhibition by valproic acid and trichostatin A

  2005cited by this paper
• Estrogen Receptor-Directs Ordered , Cyclical , and Combinatorial Recruitment of Cofactors on a Natural Target

  2003cited by this paper
• Expression of phosphorylated histone H2AX as a surrogate of cell killing by drugs that create DNA double-strand breaks.

  2003influential reference
• Cyclic, proteasome-mediated turnover of unliganded and liganded ERalpha on responsive promoters is an integral feature of estrogen signaling.

  2003cited by this paper
• Human estrogen receptor-alpha: regulation by synthesis, modification and degradation.

  2002cited by this paper
• Human estrogen receptor-α: regulation by synthesis, modification and degradation

  2002cited by this paper
• Leukemias related to treatment with DNA topoisomerase II inhibitors.

  2001cited by this paper
• Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription.

  2000cited by this paper
• Human Tumor Xenografts: Predictivity, Characterization and Discovery of New Anticancer Agents

  1999cited by this paper
• A role for the amino terminus of human topoisomerase I.

  1998cited by this paper
• DNA Content Measurement for DNA Ploidy and Cell Cycle Analysis

  1997cited by this paper
• Current Protocols In Cytometry

  1997cited by this paper
• Pharmacological characterization of the murine and human orthologs of multidrug-resistance protein in transfected human embryonic kidney cells.

  1997cited by this paper
• Activation of estrogen receptor-mediated gene transcription by IGF-I in human breast cancer cells.

  1997cited by this paper
• Polyethylenimine (PEI) is a simple, inexpensive and effective reagent for condensing and linking plasmid DNA to adenovirus for gene delivery

  1997cited by this paper
• Modulation of DNA topoisomerase I activity by p53.

  1996cited by this paper
• 5-Nitrofuran derivatives of fatty acid hydrazides induce differentiation in human myeloid leukaemic cell lines.

  1995cited by this paper
• Dose-intensive therapy in small cell lung cancer.

  1995cited by this paper
• Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs.

  1994cited by this paper
• Heat stress induces hsc70/nuclear topoisomerase I complex formation in vivo: evidence for hsc70-mediated, ATP-independent reactivation in vitro.

  1994cited by this paper
• DNA topoisomerase I is involved in both repression and activation of transcription

  1993cited by this paper
• Studies on the antineoplasticity of Schiff bases containing 5-nitrofuran and pyrimidine.

  1990cited by this paper
• Mutagenicity of nitrofuran derivatives: review.

  1983cited by this paper
• Drug therapy reviews: nitrofurantoin.

  1979cited by this paper
• May 1

  1965cited by this paper
• The reduction of Furacin by cell-free extracts of Furacin-resistant and parent-susceptible strains of Escherichia coli.

  1957cited by this paper
• Studies on the action of nitrofurans on bacterial enzyme systems. I. The inhibition of bacterial respiration by furacin.

  1951cited by this paper
• Studies on the action of nitrofurans on bacterial enzyme systems. I. The inhibition of bacterial respiration by furacin.

  1951cited by this paper

• Molecular Periphery Design Allows Control of the New Nitrofurans Antimicrobial Selectivity

  2024cites this paper
• Design and synthesis of novel 4-thiazolidinone derivatives with promising anti-breast cancer activity: Synthesis, characterization, in vitro and in vivo results.

  2020cites this paper
• Toward a repositioning of the antibacterial drug nifuroxazide for cancer treatment.

  2019cites this paper
• Microwave synthesis of novel halogenated β-enaminonitriles linked 9-bromo-1H-benzo[f]chromene moieties: Induces cell cycle arrest and apoptosis in human cancer cells via dual inhibition of topoisomerase I and II.

  2019cites this paper
• Identification of topoisomerases as molecular targets of cytosporolide C and its analog.

  2019cites this paper
• Novel seleno- and thio-urea derivatives with potent in vitro activities against several cancer cell lines.

  2016cites this paper
• Contemporary challenges in the design of topoisomerase II inhibitors for cancer chemotherapy.

  2012cites this paper
• Discovery of ortho-Carborane-Conjugated Triazines as Selective Topoisomerase I/II Inhibitors

  2011cites this paper
• Marinactinones A–C, new γ-pyrones from marine actinomycete Marinactinospora thermotolerans SCSIO 00606

  2011cites this paper
• Eeyarestatin 1 Interferes with Both Retrograde and Anterograde Intracellular Trafficking Pathways

  2011cites this paper
• opoisomerase II inhibitors

  2008cites this paper
• AVALIAÇÃO DA ATIVIDADE APOPTÓTICA DE SUBSTÂNCIA PURA ISOLADA DE Cryptocarya mandioccana EM CÉLULAS DE CARCINOMA CERVICAL IMORTALIZADAS PELO PAPILOMAVÍRUS HUMANO (HPV).

  2007cites this paper